Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

BioCryst Pharmaceuticals Says It Expects To Achieve Full-year Operating Profit In 2024, Approach Quarterly Positive EPS And Positive Cash Flow In 2H Of 2025, And Be Profitable On An EPS Basis, With Positive Cash Flow, For Full Year 2026

Author: Benzinga Newsdesk | August 05, 2024 07:07am

Posted In: BCRX